益盛药业
(002566)
| 流通市值：18.80亿 | | | 总市值：26.84亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 476,195,233.12 | 327,825,957.9 | 159,128,536.54 | 668,468,926 |
| 营业收入 | 476,195,233.12 | 327,825,957.9 | 159,128,536.54 | 668,468,926 |
| 二、营业总成本 | 461,908,412.48 | 316,644,266.73 | 148,077,625.71 | 640,516,780.87 |
| 营业成本 | 118,512,783.81 | 81,464,411.54 | 39,980,766.05 | 170,640,668.91 |
| 税金及附加 | 12,117,786.86 | 8,072,240.08 | 4,044,553.16 | 16,014,107.3 |
| 销售费用 | 237,468,154.46 | 163,225,755.64 | 76,154,213.27 | 331,962,541.02 |
| 管理费用 | 72,647,166.77 | 49,560,785.47 | 21,008,731.19 | 98,100,850.88 |
| 研发费用 | 11,554,503.24 | 8,033,282.78 | 3,886,170.86 | 16,224,404.19 |
| 财务费用 | 9,608,017.34 | 6,287,791.22 | 3,003,191.18 | 7,574,208.57 |
| 其中:利息费用 | 9,922,335.84 | 6,526,527.77 | 3,225,556.51 | 13,844,030.81 |
| 其中:利息收入 | 419,692.74 | 319,002.48 | 255,713.41 | 6,405,885.13 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -5,629,868.61 | -5,163,499.61 | 1,032,961.81 | 6,689,479.59 |
| 加:投资收益 | 11,565,434.04 | 11,471,517.38 | -158,773.13 | 5,285,761.43 |
| 资产处置收益 | 282,362.32 | 282,362.32 | - | 291,436.9 |
| 资产减值损失(新) | - | - | - | -1,590,887.57 |
| 信用减值损失(新) | -1,834,815.19 | -1,981,582.18 | -1,209,815.39 | -22,220.28 |
| 其他收益 | 10,134,877.71 | 6,993,424.1 | 3,564,183.25 | 22,755,117.72 |
| 四、营业利润 | 28,804,810.91 | 22,783,913.18 | 14,279,467.37 | 61,360,832.92 |
| 加:营业外收入 | 501.76 | 501.76 | 155,207.59 | 71,182.51 |
| 减:营业外支出 | 988,595.81 | 316,672.94 | 129,890.95 | 1,884,142.71 |
| 五、利润总额 | 27,816,716.86 | 22,467,742 | 14,304,784.01 | 59,547,872.72 |
| 减:所得税费用 | 3,397,925.85 | 2,641,718.26 | 2,268,147.59 | 8,891,478.9 |
| 六、净利润 | 24,418,791.01 | 19,826,023.74 | 12,036,636.42 | 50,656,393.82 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 24,418,791.01 | 19,826,023.74 | 12,036,636.42 | 50,656,393.82 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 24,128,318.5 | 18,763,756.04 | 11,861,570.02 | 52,086,058.77 |
| 少数股东损益 | 290,472.51 | 1,062,267.7 | 175,066.4 | -1,429,664.95 |
| 扣除非经常损益后的净利润 | 12,561,156.24 | 8,716,737.65 | 8,438,573.7 | 27,064,642.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.07 | 0.06 | 0.04 | 0.16 |
| (二)稀释每股收益 | 0.07 | 0.06 | 0.04 | 0.16 |
| 九、综合收益总额 | 24,418,791.01 | 19,826,023.74 | 12,036,636.42 | 50,656,393.82 |
| 归属于母公司股东的综合收益总额 | 24,128,318.5 | 18,763,756.04 | 11,861,570.02 | 52,086,058.77 |
| 归属于少数股东的综合收益总额 | 290,472.51 | 1,062,267.7 | 175,066.4 | -1,429,664.95 |
| 公告日期 | 2025-10-27 | 2025-08-23 | 2025-04-24 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |